A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer. [electronic resource]
Producer: 19990930Description: 1299-305 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cohort Studies
- Doxorubicin -- administration & dosage
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Recurrence
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.